Literature DB >> 7029260

Human saliva inactivates mutagenicity of carcinogens.

H Nishioka, K Nishi, K Kyokane.   

Abstract

Mutagenicities of AF-2, MNNG, 4NQO, aflatoxin B1, benzo [a] pyrene and Trp-P-1, with or without metabolic activation, were inactivated by treatment with human saliva to a great extent in the Ames test with Salmonella typhimurium test strains TA98 and TA100. Mutagenic activities of quercetin, pyrolysates of beef, salmon and sodium glutamate, and condensate of cigarette smoke were also decreased to some extent by saliva treatment, but no significant effect was found on the activity of MMS and pyrolysate of polypeptone. These effects showed individual variations. The inhibition of AF-2 mutagenicity by saliva varied with temperature in TA100 but not in TA98 cultures. Boiled saliva inactivated AF-2 mutagenicity in TA98 to some extent but not in TA100 cultures. Inactivation of AF-2 mutagenicity by saliva treatment was completed within 30 sec. Complex mechanisms may be involved in the inactivation of mutagenicity of carcinogens by saliva, including biochemical reactions with enzymes, vitamins, etc. and/or adsorption with high molecular weight substances in saliva such as proteins, bacterial cells, mucous materials, etc.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7029260     DOI: 10.1016/0165-1161(81)90223-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

1.  Response of salivary peroxidase to exercise intensity.

Authors:  A Damirchi; M Kiani; V Jafarian; Reyhaneh Sariri
Journal:  Eur J Appl Physiol       Date:  2009-12-25       Impact factor: 3.078

Review 2.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

3.  Daily lifestyles and anti-mutagenicity of saliva.

Authors:  Masahiro Toda; Kanehisa Morimoto; Sei-Ichi Nakamura; Kazuo Hayakawa
Journal:  Environ Health Prev Med       Date:  2002-04       Impact factor: 3.674

4.  The unique correlation between anti-mutagenicity of human saliva and change in body weight.

Authors:  M Toda; K Morimoto; S Nakamura; T Umeda; S Nakaji; K Sugawara
Journal:  Environ Health Prev Med       Date:  2001-07       Impact factor: 3.674

5.  A further note on the sampling device for the anti-mutagenicity of saliva.

Authors:  Masahiro Toda; Kanehisa Morimoto; Sei-Ichi Nakamura; Kazuo Hayakawa
Journal:  Environ Health Prev Med       Date:  2002-04       Impact factor: 3.674

Review 6.  [Alcohol related diseases of the head and neck].

Authors:  F Riedel; K Hörmann
Journal:  HNO       Date:  2004-07       Impact factor: 1.284

7.  Micronucleus--an upcoming marker of genotoxic damage.

Authors:  Mala Kamboj; Sumita Mahajan
Journal:  Clin Oral Investig       Date:  2006-10-10       Impact factor: 3.606

Review 8.  Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma.

Authors:  Zhen-Ge Lei; Xiao-Hua Ren; Sha-Sha Wang; Xin-Hua Liang; Ya-Ling Tang
Journal:  Onco Targets Ther       Date:  2016-01-27       Impact factor: 4.147

9.  Direct assessment of the antioxidant property of salivary histatin.

Authors:  Tomoko Komatsu; Kyo Kobayashi; Eva Helmerhorst; Frank Oppenheim; Masaichi Chang-Il Lee
Journal:  J Clin Biochem Nutr       Date:  2019-10-08       Impact factor: 3.114

10.  Saliva--a pivotal player in the pathogenesis of oropharyngeal cancer.

Authors:  A Z Reznick; O Hershkovich; R M Nagler
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.